KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) EBIT (2016 - 2025)

Nu Skin Enterprises' EBIT history spans 17 years, with the latest figure at $23.2 million for Q4 2025.

  • For Q4 2025, EBIT rose 143.79% year-over-year to $23.2 million; the TTM value through Dec 2025 reached $65.8 million, up 143.38%, while the annual FY2025 figure was $65.8 million, 143.38% up from the prior year.
  • EBIT for Q4 2025 was $23.2 million at Nu Skin Enterprises, up from $21.6 million in the prior quarter.
  • Across five years, EBIT topped out at $85.4 million in Q2 2021 and bottomed at -$125.6 million in Q2 2024.
  • The 5-year median for EBIT is $21.0 million (2021), against an average of $15.4 million.
  • The largest YoY upside for EBIT was 169.15% in 2024 against a maximum downside of 430.46% in 2024.
  • A 5-year view of EBIT shows it stood at $20.3 million in 2021, then surged by 35.14% to $27.5 million in 2022, then plummeted by 41.5% to $16.1 million in 2023, then plummeted by 430.46% to -$53.1 million in 2024, then skyrocketed by 143.79% to $23.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's EBIT are $23.2 million (Q4 2025), $21.6 million (Q3 2025), and $30.8 million (Q2 2025).